Abstract

Immune-related adverse events (irAEs) occur in almost every organ system in a seemingly unpredictable fashion, causing substantial morbidity and mortality. Lozano etal.1 report peripheral blood profiling from patients receiving immune checkpoint inhibitors, identifying that diverse CD4+ effector memory Tcells present prior to treatment are associated with severe irAEs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call